Answers are grounded in this paper and cite their sources.
Disease lesions are typically defined by morphology, yet this classification often masks underlying structural heterogeneity. In Alzheimer's disease (AD), amyloid-β (Aβ) plaques appear as featureless deposits under conventional microscopy, obscuring distinct sub-regions with divergent packing, maturation, and pathological potential. Here, we present Probe-Assisted Structural Topography of Amyloid (PASTA), a single-staining framework that combines a novel pan-Aβ probe (NapIM) with fluorescence lifetime-resolved detection and super-resolution microscopy to unmask this hidden complexity. Leveraging PASTA, we quantify plaque maturity via the Protofibril Index (PFI) at sub-lesion level, and resolve the three-dimensional (3D) in-tissue architecture of Aβ plaques at ~30 nm resolution, identifying radially extended Aβ branches as fundamental structural units. PASTA enables structural mapping across plaque developmental stages to reconstruct their dynamic growth trajectories, resolving two distinct assembly lineages (dense and loose) with divergent growth paths that converge to a mixed terminal subtype and share a common transition point. We further applied PASTA for mapping microglial engagement, linking interdigitated microglial contacts to dense plaque compaction and uncontacted fibril branches to loose morphology. Together, PASTA provides an unprecedented framework for understanding Aβ heterogeneity, nanoscale architecture, and microglial-mediated remodeling in AD.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: